{"id":"phosphoethanolamine","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT02950103","NCT04975724","NCT00153790","NCT01694004","NCT05689424","NCT04383288","NCT01976156","NCT00001012","NCT04423094","NCT03468179","NCT01902069","NCT00631631"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"Phosphoethanolamine","companyId":"secretaria-de-estado-da-sa-de","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Secretaria de Estado da Saúde","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"}],"genericName":"Phosphoethanolamine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02950103","phase":"Phase 2","title":"Efficacy and Safety Evaluation of Synthetic Phosphoethanolamine in Solid Tumor Patients","status":"TERMINATED","sponsor":"Secretaria de Estado da Saúde","isPivotal":false,"enrollment":73,"indication":"Solid Tumor","completionDate":"2019-09"},{"nctId":"NCT04975724","phase":"Phase 4","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Assess Safety and Effectiveness of Liposom in Enhance and Speed up Response With Citalopram in Elderly Patients Suffering ","status":"UNKNOWN","sponsor":"Fidia Farmaceutici s.p.a.","isPivotal":false,"enrollment":150,"indication":"Major Depressive Disorder","completionDate":"2025-12"},{"nctId":"NCT00153790","phase":"Phase 1","title":"The Effect of Soy Lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and Green Tea-derived Epigallocatechin Gallate (EGCG) on Indices of Weight Loss and Appetite Suppression","status":"COMPLETED","sponsor":"The Cooper Institute","isPivotal":false,"enrollment":60,"indication":"Weight Loss","completionDate":"2006-05"},{"nctId":"NCT01694004","phase":"Phase 1","title":"Duodenal Lipid Sensing and Nutrient Absorption","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","isPivotal":false,"enrollment":16,"indication":"The Effect of LCFA on Nutrient Absorption","completionDate":"2014-10-27"},{"nctId":"NCT05689424","phase":"Phase 1","title":"Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Diego","isPivotal":false,"enrollment":18,"indication":"Type 1 Diabetes","completionDate":"2026-06-30"},{"nctId":"NCT04383288","phase":"N/A","title":"Prospective Observational Study of the Expression of ABCB1 / P-glycoprotein as a Factor for the Biological Stratification of Non-metastatic Osteosarcoma of the Extremities","status":"COMPLETED","sponsor":"Grupo Espanol de Investigacion en Sarcomas","isPivotal":false,"enrollment":115,"indication":"Osteosarcoma","completionDate":"2020-10-17"},{"nctId":"NCT01976156","phase":"NA","title":"The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity","status":"COMPLETED","sponsor":"Yale University","isPivotal":false,"enrollment":100,"indication":"Neural Response in Caudate, Weight Loss Trial","completionDate":"2017-10"},{"nctId":"NCT00001012","phase":"Phase 1","title":"An Open Label, Multiple Dose Ranging Trial of AL721 in Patients With Persistent Generalized Lymphadenopathy and Symptomatic HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":50,"indication":"HIV Infections","completionDate":""},{"nctId":"NCT04423094","phase":"N/A","title":"Foci of Tumor Heterogeneity in IDH1-mutated Diffuse Low-Grade Gliomas Reveal STAT3 Activation and Downregulation of the Phosphoethanolamine Enzyme ETNPPL Acting as a Negative Regulator of Glioma Growt","status":"COMPLETED","sponsor":"University Hospital, Montpellier","isPivotal":false,"enrollment":8,"indication":"Glioma","completionDate":"2019-03-30"},{"nctId":"NCT03468179","phase":"NA","title":"Acute Effects of Dietary Oatmeal on Serum Levels of N-acyl-phosphatidylethanolamines and Their Metabolites.","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","isPivotal":false,"enrollment":10,"indication":"Obesity, Cardiovascular Diseases","completionDate":"2018-12-31"},{"nctId":"NCT01902069","phase":"NA","title":"The Gut-brain Axis in Food Reward and Alcohol Consumption","status":"COMPLETED","sponsor":"Yale University","isPivotal":false,"enrollment":29,"indication":"Impulsivity, Alcohol Consumption","completionDate":"2014-11"},{"nctId":"NCT00631631","phase":"N/A","title":"Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine (L-MTP-PE) for High-risk Osteosarcoma","status":"COMPLETED","sponsor":"Millennium Pharmaceuticals, Inc.","isPivotal":false,"enrollment":205,"indication":"Osteosarcoma","completionDate":"2012-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}